Skip to search formSkip to main contentSkip to account menu

BRL-38226

Known as: BRL 38226, BRL38226 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

BenzopyransCromakalimPyrroles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The effects of racemic cromakalim, BRL 38226 and levcromakalim on the membrane potential of the rat aorta and of BRL 38226 on the contractile activity of the rat aorta and portal vein.
The effects of racemic cromakalim and the (+)-3R,4S and (-)-3S,4R isomers, BRL 38226 and levcromakalim respectively, on the… 
1993
1993
Cromakalim inhibits electrically-evoked [3H] acetylcholine release from a tube-preparation of the rat isolated trachea by an epithelium-dependent mechanism
SummaryRat isolated tracheae were labelled by incubation with [3H]choline to measure the tritium efflux elicited by electrical… 
1991
1991
Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models.
The present studies describe the blood pressure lowering, and some other haemodynamic effects, of the potassium channel activator… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)